Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Cash from Investing Activities: 2016-2024

Historic Cash from Investing Activities for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to -$10.0 million.

  • Organogenesis Holdings' Cash from Investing Activities rose 13.00% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.9 million, marking a year-over-year decrease of 28.66%. This contributed to the annual value of -$10.0 million for FY2024, which is 58.82% up from last year.
  • Latest data reveals that Organogenesis Holdings reported Cash from Investing Activities of -$10.0 million as of FY2024, which was up 58.82% from -$24.4 million recorded in FY2023.
  • Over the past 5 years, Organogenesis Holdings' Cash from Investing Activities peaked at -$10.0 million during FY2024, and registered a low of -$33.9 million during FY2022.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$24.4 million (2023), whereas its average is -$22.8 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Cash from Investing Activities slumped by 276.93% in 2020, and later soared by 58.82% in 2024.
  • Over the past 5 years, Organogenesis Holdings' Cash from Investing Activities (Yearly) stood at -$23.5 million in 2020, then plummeted by 32.86% to -$31.2 million in 2021, then decreased by 8.58% to -$33.9 million in 2022, then increased by 28.13% to -$24.4 million in 2023, then skyrocketed by 58.82% to -$10.0 million in 2024.